Locally aberrant methylation has been previously described in CLL cells when compared with normal CD19+ B cells and has the potential for gene silencing and inactivation of genes related to normal tissue homeostasis [13,25]. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.